Synergic interaction between ritodrine and magnesium sulfate on the occurrence of critical neonatal hyperkalemia: A Japanese nationwide retrospective cohort study
Yukari Yada,Akihide Ohkuchi,Katsufumi Otsuki,Keiji Goishi,Mari Takahashi,Naohiro Yonemoto,Shigeru Saito,Satoshi Kusuda,Survey Group Studying the Effects of Tocolytic Agents on Neonatal Adverse Events in Japan Society of Perinatal and Neonatal Medicine,Hajime Ota,Kiyotaka Kosugiyama,Kazuhiko Okuyama,Masato Mizushima,Hideaki Negishi,Shinichi Koshida,Mayumi Kasai,Motonari Okabe,Akira Sato,Hiroyuki Adachi,Michio Banzai,Kazuhiro Akaba,Rika Suzuki,Naohisa Ishibashi,Takashi Watanabe,Yoshio Kasuga,Takashi Kameda,Toru Fujiu,Takeshi Takagi,Kenichi Maruyama,Masahiko Higashino,Tomomi Naito,Yoshimasa Kamei,Tetsuya Kunikata,Yoshinori Iitsuka,Harumi Otsuka,Yuka Yamamoto,Mie Yamada,Masaki Daigo,Hironobu Hyodo,Ayumi Sato,Noriko Kataoka,Satoko Yamanaka,Aya Okahashi,Yuki Kojima,Shigenori Kabashima,Yoshie Nakamura,Rina Okuno,Seiko Hirose,Koichi Sugahara,Satsuki Okamoto,Sumiko Hara,Wakako Shima,Takeshi Suzuki,Hideyuki Kagawa,Kenichiro Fujioka,Akiko Kurasaki,Ayako Miura,Isamu Hokuto,Toru Arase,Nobuhiko Taguchi,Kazuki Sekiguchi,Tomoyo Matsuo,Emi Ohnuma,Kana Fujiwara,Miyuki Ogawa,Azusa Uozumi,Noriyuki Yokomichi,Akane Hirose,Mika Okuda,Ayako Fukuyama,Hitoshi Ishimoto,Kanako Mitsuzuka,Shinya Kondo,Miyuki Kitazawa,Norihiko Kikuchi,Yumiko Miyashita,Chiharu Tsutsumi,Shuhei Terada,Shigeru Ohki,Takakazu Kawamura,Masako Yasuda,Yoshiki Soeno,Takumi Kurabayashi,Yoshihisa Nagayama,Satoshi Yoneda,Tomomi Shiga,Seiji Hayashi,Hiroyuki Tsuda,Makoto Oshiro,Takafumi Ushida,Teruyuki Mizutani,Hideyuki Asada,Ryousuke Miura,Ryo Tanaka,Noriko Kato,Yuko Sasaki,Takehiko Yokoyama,Takako Hirooka,Takaharu Yamada,Kaori Maruwaka,Syunsuke Nagara,Satoko Fukaya,Mari Koroki,Taihei Tanaka,Shigehiko Morikawa,Shigeru Honda,Haruki Sassa,Takeshi Sahashi,Hiroko Torii,Tadahiro Yasuo,Nozomi Kuriyama,Juzo Okada,Moe Kano,Noriyoshi Oki,Mieko Inagaki,Yousuke Mizuno,Masayo Fujisaka,Akihiro Takatera,Takeo Mure,Katsuhiko Yoshii,Yasuko Furuichi,Akiko Kanto,On Fukui,Shusaku Hayashi,Hitomi Ono,Eri Fujikawa,Masayuki Someya,Makiko Ikeda,Kentaro Nakanishi,Akiko Yamashita,Haruna Kawaguchi,Ryo Yamamoto,Jun Sasahara,Takeshi Kanagawa,Satoshi Yamamoto,Yosuke Imanishi,Misuzu Yoshida,Eri Yano,Ayumi Murayama,Kazue Morikawa,Natsuko Tabata,Ryosuke Araki,Eriko Iwasaki,Narutaka Mochizuki,Akiko Kobayashi,Akiko Takeda,Masaya Hirose,Nao Taguchi,Hiroshi Sato,Kenji Oida,Rie Sakai,Saeko Imai,Reona Shiro,Minami Okudate,Yoko Matsuda,Yoshinobu Nishida,Aya Toyofuku,Shigeto Hara,Hiroko Kurioka,Tomoya Mizunoe,Syouhei Eto,Takahiro Nobuzane,Kousyou Higuchi,Terumi Miwa,Keiko Hasegawa,Yuko Matsubara,Masaaki Ohta,Takafumi Watanabe,Takako Ohmaru-Nakanishi,Kana Kashinoura,Maki Goto,Hiroshi Kanda,Kiyomi Tsukimori,Yasushi Takahata,Makoto Nomiyama,Toshimitsu Takayanagi,Syuichiro Yoshimura,Kouhei Kotera,Hisanobu Fukuda,Hiroko Hiraki,Noriko Nagata,Kazuhisa Nakashima,Junya Miyoshi,Takafumi Obara,Kentaro Kai,Yuichi Furukawa,Satoshi Eto,Tomoko Oishi,Misaki Nakashima,Aya Yamauchi,Yuki Kodama,Takako Ohata,Haruka Arakaki,Kei Miyakoshi,Mariko Hida
DOI: https://doi.org/10.1038/s41598-020-64687-w
2020-05-08
Abstract:Our aim was to evaluate the association between ritodrine and magnesium sulfate (MgSO4) and the occurrence of neonatal hyperkalemia or hypoglycemia among late preterm infants in a retrospective cohort study. We used a nationwide obstetrical database from 2014. A total of 4,622 live preterm infants born at 32-36 gestational weeks participated. Fourteen risk factors based on both clinical relevance and univariate analysis were adjusted in multivariable logistic regression analyses. Neonatal hyperkalemia and hypoglycemia occurred in 7.6% (284/3,732) and 32.4% (1,458/4,501), respectively. Occurrence of hyperkalemia was associated with concomitant usage of ritodrine and MgSO4 compared with no usage (adjusted odds ratio [aOR] 1.53, 95% confidence interval [CI] 1.09-2.15). Occurrence of hypoglycemia was associated with ritodrine alone (aOR 2.58 [CI 2.21-3.01]) and with concomitant usage of ritodrine and MgSO4 (aOR 2.59 [CI 2.13-3.15]), compared with no usage, and was associated with long-term usage (≥ 48 hours) of ritodrine and cessation directly before delivery. In conclusion, in late preterm infants, usage of ritodrine together with MgSO4 was associated with occurrence of critical neonatal hyperkalemia, and long-term usage of ritodrine and cessation directly before delivery were associated with neonatal hypoglycemia.